HAMPTON, N.J. , Nov. 10, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following investor conferences in November: Guggenheim 4 th Annual Immunology and Neurology Conference on Monday, November 14,